Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Pharmacotherapy|July 25, 2000
Adverse events associated with chemotherapy for common cancersV R AdamsPharmacology & Therapeutics|October 22, 2013
CHEK again: revisiting the development of CHK1 inhibitors for cancer therapyS McNeely, R Beckmann, A K Bence LinJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)|October 26, 1999
Oprelvekin (Neumega), first platelet growth factor for thrombocytopeniaV R Adams, T BrennerThe Annals of Pharmacotherapy|December 1, 1995
Granisetron: the second serotonin-receptor antagonistV R Adams, A W ValleyJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)|February 28, 1998
Cancer vaccines (1)P A Hallin, V R AdamsJournal of the American Pharmaceutical Association (Washington, D.C. : 1996)|January 13, 1998
Cancer vaccines. Part 2P A Hallin, V R AdamsBioorganic & Medicinal Chemistry Letters|December 29, 2000
Aminoanthraquinones as novel ligands at the polyamine binding site on the N-methyl-D-aspartate receptor complexA K Bence, D T Rogers, D R Worthen, et al.Brain Research|February 13, 2001
Endogenous indoles as novel polyamine site ligands at the N-methyl-D-aspartate receptor complexD R Worthen, D A Gibson, D T Rogers, et al.The Annals of Pharmacotherapy|October 31, 2000
Computerized system for outcomes-based antiemetic therapy in childrenM T Holdsworth, V R Adams, D W Raisch, et al.The Annals of Pharmacotherapy|January 1, 1995
Continuous midazolam infusion for the management of morphine-induced myoclonusM T Holdsworth, V R Adams, C M Chavez, et al.Pageof 2